课题基金 / 基金详情

Immunomodulatory effects of omega-3 polyunsaturated fatty acids : role in allergy prevention in infancy

Immunomodulatory effects of omega-3 polyunsaturated fatty acids : role in allergy prevention in infancy
omega-3 多不饱和脂肪酸的免疫调节作用:在婴儿期过敏预防中的作用
批准号:
nhmrc : 353555
负责人:
A/Pr Charles Hii
金额:
$35.85万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2005
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2005-01-01 至 2007-12-31

项目摘要

项目成果

A/Pr Charles Hii的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The dramatic increase in asthma and allergic disease over the last 20-30 years has highlighted the urgent need to identify associated environmental changes that may also be logical targets for disease prevention. Although this is likely to be multifactorial, one significant change during this period has been a progressive decline in the intake of dietary anti-inflammatory n-3 polyunsaturated fats (PUFA) in Western diets, with a corresponding increase in n-6 PUFA fatty acids. We recently showed for the first time that n-3 PUFA may have more significant effects in very early life before immune responses are fully established. We confirmed that maternal fish oil supplementation (n-40) resulted in significantly higher n-3 PUFA levels in newborns (compared to those with no supplements, n-43), and this was related to reduced immune responses to allergens (such as house dust mite, cat and egg). These observations suggest that n-3 PUFA can modify early immune development. Although this previous study was designed to assess immune outcomes (rather than clinical outcomes) we collected preliminary clinical data for the purposes of this application. We observed a consistent trend for less allergic symptoms and sensitisation in the supplementation group. These observations clearly warrant this proposed study to confirm these clinical effects, and to assess the mechanisms of action in considerably more detail. In this proposed study we will compare the effects of fish oil (n-165) or placebo (n-165) in early infancy (from 0-6 months of age). This much larger population will allow us to determine if increasing dietary n-3 PUFA is a way of reducing the chance of allergy in families where there is a high genetic risk. Approximately 40% of infants in Australia will go on to develop asthma or allergies. Strategies such as this that reduce the risk (even slightly) or the severity of disease expression could have enormous impact in this global context at relatively little cost.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Treating hyperglycaemia in diabetes with polyunsaturated fatty acid analogues
  • 批准号:
    nhmrc : 1011133
  • 项目类别:
    Project Grants
  • 资助金额:
    $40.16万
  • 财政年份:
    2011
  • 负责人:
    A/Pr Charles Hii
  • 依托单位:
Characterisation of the anti-inflammatory properties of the n-3 fatty acid product, 4-hydroxy-hexenal.
  • 批准号:
    nhmrc : 508041
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $34.98万
  • 财政年份:
    2008
  • 负责人:
    A/Pr Charles Hii
  • 依托单位:
T cell PKC expression as a novel neonatal predictor and modulator of allergic disease.
  • 批准号:
    nhmrc : 513709
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $37.2万
  • 财政年份:
    2008
  • 负责人:
    A/Pr Charles Hii
  • 依托单位:
Omega 3 polyunsaturated fatty acid analogues in the treatment of diabetic complications
  • 批准号:
    nhmrc : 453464
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $27.9万
  • 财政年份:
    2007
  • 负责人:
    A/Pr Charles Hii
  • 依托单位:
国内基金
海外基金
Dynamic Credit Rating with Feedback Effects
  • 批准号:
    --
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    Christian Martin Hilpert
  • 依托单位:
NPM1表观重塑巨噬细胞代谢及修复表型在心肌缺血损伤中的调控作用
  • 批准号:
    82371825
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    占贞贞
  • 依托单位:
内源性蛋白酶抑制剂SerpinA3N对缺血性脑卒中后血脑屏障的保护作用及其表达调控机制
  • 批准号:
    82371317
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    万杰清
  • 依托单位:
儿童期受虐经历影响成年人群幸福感:行为、神经机制与干预研究
  • 批准号:
    32371121
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2023
  • 负责人:
    孔风
  • 依托单位: